Mirtazapine Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comparative Safety of Antidepressants in Adults with CKD
CONCLUSIONS: Antidepressant treatment was associated with short-term adverse outcomes but not long-term outcomes in people with CKD and depression.PMID:38032000 | DOI:10.2215/CJN.0000000000000348 (Source: Clinical Journal of the American Society of Nephrology : CJASN)
Source: Clinical Journal of the American Society of Nephrology : CJASN - November 30, 2023 Category: Urology & Nephrology Authors: Nanbo Zhu Hong Xu Tyra Lagerberg Kristina Johnell Juan Jes ús Carrero Zheng Chang Source Type: research

Sertraline with desvenlafaxine and sertraline with mirtazapine as treatment initiation in MDD patients with moderate to severe depression and effect on inflammatory markers
CONCLUSION: The present study suggests that the combination therapy (as treatment initiation) with sertraline and desvenlafaxine, and sertraline with mirtazapine is effective and well tolerated in MDD patients with moderate to severe depression, and their therapeutic efficacy is accompanied by decreased inflammatory markers (serum IL-6 and TNF-α).PMID:38019131 | DOI:10.1080/13651501.2023.2287754 (Source: International Journal of Psychiatry in Clinical Practice)
Source: International Journal of Psychiatry in Clinical Practice - November 29, 2023 Category: Psychiatry Authors: Norman Arockiaraj Rachna Gupta Rafat Ahmad Sumita Halder M S Bhatia Source Type: research